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ABSTRACT   
A retrospective pilot clinical study on time domain multi-wavelength (635 to 1060 nm) optical mammography was 
exploited to assess collagen as a breast-cancer risk factor on a total of 109 subjects (53 healthy and 56 with malignant 
lesions). An increased cancer occurrence is observed on the 15% subset of patients with higher age-matched collagen 
content. Further, a similar clustering based on the percentage breast density leads to a different set of patients, possibly 
indicating collagen as a new independent breast cancer risk factor. If confirmed statistically and on larger numbers, these 
results could have huge impact on personalized diagnostics, health care systems, as well as on basic research.  
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1. INTRODUCTION  
The identification of risk factors for breast cancer is a relevant open quest. The chance to identify clusters of subjects at 
high risk permits to foresee personalized diagnostics paths on smaller groups – not sustainable in population-wide 
screening programs. Indeed, the early diagnosis of breast cancer (size <1cm, no lymphnode involvement) leads to an 
impressive 95% complete remission rate. Breast density is recognized as a strong and independent risk factor for breast 
cancer and is usually quantified by X-ray mammography. Recently, optical techniques have been shown to offer a valid 
non-invasive and possibly cost-effective alternative for the assessment of breast density even at young age1-3. 
In this paper we explore an even more ambitious goal, which is to investigate whether optical techniques can be used 
directly to assess breast cancer risk factors and not just indirectly by correlation with breast density. More specifically, 
we address collagen – quantified by time-resolved diffuse optical spectroscopy4 – as a potential independent risk factor 
for breast cancer5.  
2. MATERIALS AND METHODS 
2.1. Instrument set-up 
Time-resolved transmittance scans are performed at 7 wavelengths (635, 685, 785, 905, 930, 975, 1060 nm) using pulsed 
diode lasers and time-correlated single photon counting4. The compressed breast is scanned continuously recording data 
every mm. The central region of the breast, far from boundaries, is used for assessment of breast optical properties. A 
schematics of the instrument is shown in Fig. 1. 
2.2. Patient study 
For the purpose of this investigation, a total of 109 patients were included following criteria of i) availability of digital 
mammography for percentage breast density assessment; ii) absence of technical failure (e.g. poor signal); iii) exclusion 
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of patients with benign lesions or not clearly classified malignant lesions (e.g. DCS). Two subsets of 53 healthy subjects 
(normal) and 56 patients bearing a malignant lesion (cancer) were extracted.  
2.3. Data analysis 
Tissue composition and structure is obtained directly from time-resolved transmittance curves using a spectrally 
constrained global fitting procedure on the key absorber concentrations (oxy- and deoxy-hemoglobin, water, lipids, and 
collagen) together with the scattering amplitude a and power b. The collagen absorption spectrum was obtained using a 
broadband time-resolved diffuse optical spectrometer6 on bovine tendon collagen I powder purchased from Sigma7. 
An experienced radiologist evaluated percentage mammographic density using a fully automated procedure8. 
Age-matched distributions of collagen and density are obtained by dividing both the collagen content and the percentage 
density by the corresponding theoretical age-matched value obtained by a linear interpolation on the normal distribution. 
 
Figure 1. Schematics of the time-domain optical mammograph used in the clinical study. 
3. RESULTS AND DISCUSSION 
In principle, the investigation of a new potential breast cancer risk factor would require a long longitudinal study 
involving a high number of subjects to understand whether factor X detected at age Y is correlated with a later 
occurrence of cancer. Clearly, such a huge trial can be undertaken only when the initial hypothesis is explored on a much 
smaller scale. The approach we pursue here for a first insight is to address the question retrospectively, i.e. to find out 
whether subjects bearing a breast lesion have some signs in their healthy breast suggesting a higher risk factor. For this 
purpose, we exploited the outcome of a clinical study on optical mammography initially designed for the aim of 
differentiating optically malignant from benign lesions9. Just two groups are identified here, i.e. normal (healthy subject) 
and cancer (bearing a malignant lesion). 
Figure 2 displays the box plot of the collagen content and of the percentage mammographic density for the two groups. 
There is a slightly higher mean collagen content in the cancer group as compared to the normal one, yet these differences 
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are meaningless considering the high dispersion of the data. At a first sight one could conclude that the chance to use 
collagen as a breast cancer risk factor is deemed to fail. Nevertheless, a similar pattern is observed also for the percentage 
density, for which correlation with higher cancer risk is clearly demonstrated in literature. The clue here is that the 
number of subjects that get cancer because of their higher breast density is just a fraction of the total population. Thus its 
impact on the mean values is quite diluted. 
In order to investigate the possible role of collagen as a risk factor for a specific sub-group of the whole population, we 
mimicked – at first order – the known results reported for breast density. First, age-matched effective collagen values 
were derived dividing the measured quantity by the theoretical average age-matched estimates as described in 
Section 2.3. Then, the cohort of subjects with a higher collagen content are compared to the distribution observed on the 
whole population.  
Figure 3 shows the plot of the occurrence of cancer (red solid line) and normal (blue dotted line) lesions in the cohort of 
subjects with the highest age-matched collagen content. The threshold indicates the percentage of the total population 
that are included in the cohort. For a threshold around 15%, the high-collagen cohort exhibit a largest incidence of cancer 
lesions (about 80%) as compared to the total population included in this study that have a cancer incidence of 50%. This 
increase is large since we have to consider that the maximum incidence is necessarily saturated at 100%. 
To translate these numbers into increased risk factor for a standard population, where the average occurrence of cancer 
lesions is obviously much lower, a proper non-linear model must be applied. Also, more refined analysis is needed to 
assess the statistical significance of these results. 
  
Figure 2. Box plot of the collagen content (left) and percentage breast density (right) for cancer and normal subjects. 
4. CONCLUSION 
In conclusion, in a retrospective pilot clinical study involving 109 patients we show that, sorting subjects on the basis of 
age-matched collagen content, it is possible to identify an increased cancer occurrence as compared to the reference value 
on the whole population considered in the study. This means that collagen could be considered for screening purposes to 
identity women at higher risk for breast cancer. This study is still preliminary and will be further investigated on 
statistical basis and compared with results obtained using breast density as classification index. These results are 
consistent with what inferred from recent studies showing possible involvement of collagen in breast cancer onset and 
progression4, and will open new screening potential if confirmed on a larger scale. Impressive growth on photonics 
components are now opening the way to deployment of small, cost-effective, and portable time-resolved diffuse optics 
devices10,11, which could be used in simple and operator independent breast cancer risk screening programs at the level of 
the general practitioner. 
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Figure 3. Age normalized collagen vs. breast density for the cancer and the normal subjects. 
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